
Surgery for early disease:
May involve removal of one or both ovaries and fallopian tubes, the uterus, omentum and other tissues required for accurate staging.

From diagnosis and treatment planning to surgery, recovery, maintenance and follow-up, experience care that considers your strength, nutrition, reproductive health, comfort and overall wellbeing.

A diagnosis can bring many questions at once. Let us begin with the basics.
Ovarian cancer develops when abnormal cells grow in or around the ovary and form a malignant tumour. It includes several tumour types that can behave differently. The main groups are epithelial ovarian cancer, germ-cell tumours and sex cord-stromal tumours, while borderline ovarian tumours have different biological behaviour. Epithelial ovarian cancer is the most common group. Ovarian epithelial, fallopian tube and primary peritoneal cancers are closely related and are often staged and treated similarly. Early disease may cause few symptoms. Assessment can involve imaging, CA-125 and other blood tests, followed by specialist review. A definitive diagnosis generally requires examination of tumour tissue to identify the exact cancer type.
Your gynaecologic oncologist may have discussed surgery, chemotherapy, maintenance treatment, targeted medicines or other systemic therapies. Treatment depends on tumour type, stage, whether complete surgery is possible, molecular findings, previous treatment, general health and fertility goals.

Cancer Healer Therapy (CAM) is supportive integrative care used alongside treatment prescribed by your gynaecologic oncologist, not instead of it.
The supportive plan may consider appetite, fatigue, sleep, mobility, emotional wellbeing and recovery after surgery or systemic treatment.
Herbal medicines and supplements can interact with chemotherapy, bevacizumab, PARP inhibitors, immunotherapy, hormone therapy, blood thinners and medicines used around surgery.
Some products may also affect kidney or liver function, blood counts, bleeding or clotting risk, blood pressure and wound healing.
Support may begin before surgery or systemic therapy, with attention to abdominal symptoms, nutrition, bowel and urinary function, blood counts, organ function and fertility concerns.
Ovarian cancer includes several tumour types that differ in behaviour and treatment.
Borderline ovarian tumours have abnormal cells but differ from invasive ovarian carcinoma in their biological behaviour.


Here’s exactly what happens from your first conversation with us to ongoing support during treatment.
We discuss your diagnosis, pathology, scans, tumour-marker results, symptoms and current or planned oncology treatment.
The team reviews tumour type, stage, surgical findings, CA-125 when informative, BRCA or HRD findings, fertility concerns and treatment plan.
Supportive care is developed around the treatment recommended by your gynaecologic oncology team.
Herbal medicines, supplements and special diets should be disclosed to the treating doctor.
The plan may be reviewed as symptoms, blood tests, imaging and treatment needs change.
One point of contact supports appointments and follow-up communication.

Meet Dr. Tarang Krishna, MD - Cancer Healer Center
Dr. Tarang Krishna has spent over two decades developing and refining Cancer Healer Therapy, working with a multidisciplinary team across 30+ centres in India.
His work has been recognised for innovative cancer care and brings a coordinated, supportive approach to every patient journey.

Every cancer journey is personal. Read experiences shared by patients and families about the consultations, communication, follow-up and support they received at Cancer Healer Center.
4.9 Stars | 5479 Reviews
No. Most ovarian cysts are non-cancerous. Persistent, complex or enlarging masses may require specialist assessment.